• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News

    New Test to ‘Revolutionize’ TB Diagnosis, Treatment

    By Ivy Mungcal // 03 September 2010
    A man looks for smear-positive tuberculosis in a specimen. A new test for diagnosing TB could revolutionize the treatment and elimination of the disease. Photo by: Trygve Berge / CC BY NC-SA Trygve BergeCC BY NC-SA

    A new test for diagnosing tuberculosis has been developed and could revolutionize the global effort to treat and eliminate the disease, scientists and health experts have noted.

    The test, which was developed through a program funded by the Bill & Melinda Gates Foundation and the U.S. government, can reportedly diagnose tuberculosis and determine if it is drug-resistant in less than two hours, The Associated Press reports. The test has a “very high accuracy” level, scientists have noted.

    “You can tell the patient before they leave the office if they have TB and if it’s drug-resistant. It’s transformational,” Dr. Peter Small, head of the tuberculosis program at the Bill & Melinda Gates Foundation, said as quoted by AP.

    The World Health Organization is set to meet with experts in the next few days to review the test results and plan the way forward, according to one of its tuberculosis experts.

    The new test is expected to replace the century-old diagnostic process that clinics and hospitals all over the world still use and which the director of the U.S. National Institute of Allergy and Infectious Diseases describe as “antiquated.”

    Aside from the U.S. government and the Bill & Melinda Gates Foundation, the development of the test was supported by Cepheid, a California-based diagnostic firm, the University of Medicine and Dentistry in New Jersey and the Swiss-based Foundation for Innovative New Diagnostics.

    • Global Health
    • Funding
    • Innovation & ICT
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Ivy Mungcal

      Ivy Mungcal

      As former senior staff writer, Ivy Mungcal contributed to several Devex publications. Her focus is on breaking news, and in particular on global aid reform and trends in the United States, Europe, the Caribbean, and the Americas. Before joining Devex in 2009, Ivy produced specialized content for U.S. and U.K.-based business websites.

    Search for articles

    Related Stories

    Global HealthStop TB Partnership retains US funds but must revise scope, cut staff

    Stop TB Partnership retains US funds but must revise scope, cut staff

    Artificial Intelligence How AI is transforming medical diagnosis in India’s tribal regions

    How AI is transforming medical diagnosis in India’s tribal regions

    Global healthCould US foreign aid cuts fuel a superbug crisis?

    Could US foreign aid cuts fuel a superbug crisis?

    Global healthHow Trump’s aid freeze is threatening tuberculosis programs

    How Trump’s aid freeze is threatening tuberculosis programs

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      Supporting community-driven solutions to address breast cancer
    • 5
      No health reform without better AI governance
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement